In this episode of Spectrum of Health, Dr. Christine Schaffner explores the use of GLP-1 agonists in chronic illness and metabolic health. She shares her clinical insights on how these medications impact chronic infections and mast cell activation patients. Dr. Schaffner highlights the potential benefits of a microdosing approach to GLP-1s, particularly in regulating histamine release and supporting overall wellness. She also underscores the importance of long-term monitoring and a holistic perspective in patient care.

For the full show notes, please visit my website: www.drchristineschaffner.com/Episode275